Forced Degradation 18-19 January 2012

Don’t miss Europe’s only dedicated stress testing event! Plus in 2012 we have co-located Forced Degradation for Pharmaceuticals with Forced Degradation for Biologics to allow you the unique opportunity to meet and network with colleagues working in large molecules and share common experiences.

Featuring authors from the new Pharmaceutical Stress Testing: Predicting Drug Degradation, second edition, we bring you key industry thought-leaders, including speakers from Pfizer, Eli Lilly, Merck, GSK and AstraZeneca.

Addressing current topics and recent developments in the field, featured sessions include:

• Reviewing advances in knowledge of drug degradation chemistry and pathways
• Assessing the similarities and differences in developing a forced degradation strategy for large and small molecules
• Applying genotoxic impurity guidelines to forced degradation studies
• Application of forced degradation studies in drug discovery and sharing lessons learnt
• Case studies in optimizing physical and chemical stability to ensure drug product performance
• Drug Substance Degradation Studies
• Drug Product Degradation
• Assessing the predictive nature of compatibility studies and effect of excipients on degradation pathways to optimise formulation development